A 68-Year-Old Female with Advanced Renal Cell Carcinoma - Episode 3

Clinical Implications of the CHECKMATE 9ER Trial

Dr Daniel J George reviews long term follow up data from the CHECKMATE 9ER and the implications of the data in the treatment paradigm for patients with advanced renal cell carcinoma.